×
About 11,104 results

ALLMedicine Urticaria Center

Research & Reviews  4,217 results

Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children.
https://doi.org/10.1111/jdv.16666
Journal of the European Academy of Dermatology and Venereology : JEADV; Labé P, Ly A et. al.

May 26th, 2020 - We read with interest the publications in the JEADV which reported dermatological manifestations associated with COVID-19, such as pityriasis rosea, urticaria, rash, vascular signs, or chilblain-like lesions. Herein, we report two life-threatening...

Are erythema multiforme and urticaria related to a better outcome of COVID 19?
https://doi.org/10.1111/dth.13681
Dermatologic Therapy; Dastoli S, Bennardo L et. al.

May 24th, 2020 - Are erythema multiforme and urticaria related to a better outcome of COVID 19?|2020|Dastoli S,Bennardo L,Patruno C,Nisticò SP,|

Long-term follow-up effect of omalizumab in chronic spontaneous urticaria and its assoc...
https://doi.org/10.1111/dth.13663
Dermatologic Therapy; Baysak S, Kecici AS et. al.

May 24th, 2020 - This study aims to determine the efficacy of omalizumab, a humanized monoclonal anti-immunoglobulin E antibody, in patients with chronic spontaneous urticaria (CSU) refractory to conventional therapy, together with the evaluation of serum CRP leve...

Review on perfume and present status of its associated allergens.
https://doi.org/10.1111/jocd.13507
Journal of Cosmetic Dermatology; Kumar M, Devi A et. al.

May 23rd, 2020 - Perfume is basically a cosmetic product applied to human body for an amusing scent or the feeling of freshness. A certain amount of perfume penetrates and remains attached to the protein of the skin when perfume is applied on the body. It evokes a...

IgMand IgA in addition to IgG autoantibodiesagainst FcεRIα are frequent and associated ...
https://doi.org/10.1111/all.14412
Allergy Altrichter S, Zampeli V et. al.

May 23rd, 2020 - IgG-autoantibodiesagainst the high affinity IgE-receptor,FcεRIα, contribute the pathogenesis of autoimmune chronic spontaneous urticaria (CSU). However, it is not known if such patients also exhibit IgM or IgA autoantibodies against FcεRIα. To dev...

see more →

Guidelines  21 results

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and ma...
https://doi.org/10.1111/all.13397
Allergy Zuberbier T, Aberer W et. al.

Jan 17th, 2018 - This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. I...

BSACI guideline for the management of chronic urticaria and angioedema.
https://doi.org/10.1111/cea.12494
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology; Powell RJ, Leech SC et. al.

Feb 25th, 2015 - This guidance for the management of patients with chronic urticaria and angioedema has been prepared by the Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI). The guideline is based on evidence as well ...

Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/...
https://doi.org/10.1111/all.12370
Allergy Zuberbier T, Aberer W et. al.

Jun 5th, 2014 - This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured con...

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, an...
https://doi.org/10.1111/all.12313
Allergy Zuberbier T, Aberer W et. al.

May 2nd, 2014 - This guideline is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin. It i...

The diagnosis and management of acute and chronic urticaria: 2014 update
https://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Practice%20and%20Parameters/Urticaria-2014.pdf
Bernstein, J.

Apr 30th, 2014 - Theworkgroup was formed by the JTFPP to develop a practiceparameter to address the diagnosis and treatment of urticaria withor without angioedema. The chair, Jonathan Bernstein, MD,invited workgroup members to participate in the parameterdevelopme.

see more →

Drugs  1,009 results see all →

Clinicaltrials.gov  5,463 results

Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children.
https://doi.org/10.1111/jdv.16666
Journal of the European Academy of Dermatology and Venereology : JEADV; Labé P, Ly A et. al.

May 26th, 2020 - We read with interest the publications in the JEADV which reported dermatological manifestations associated with COVID-19, such as pityriasis rosea, urticaria, rash, vascular signs, or chilblain-like lesions. Herein, we report two life-threatening...

Levocetirizine dihydrochloride - levocetirizine dihydrochloride solution-Apotex Corp.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1637bb2-a54c-fb72-c86d-f5a07433cdbc

May 25th, 2020 - Levocetirizine dihydrochloride oral solution is a histamine H1-receptor antagonist indicated for: The relief of symptoms associated with perennial allergic rhinitis (1.1) The treatment of the uncomplicated skin manifestations of chronic idiopathic...

Are erythema multiforme and urticaria related to a better outcome of COVID 19?
https://doi.org/10.1111/dth.13681
Dermatologic Therapy; Dastoli S, Bennardo L et. al.

May 24th, 2020 - Are erythema multiforme and urticaria related to a better outcome of COVID 19?|2020|Dastoli S,Bennardo L,Patruno C,Nisticò SP,|

Long-term follow-up effect of omalizumab in chronic spontaneous urticaria and its assoc...
https://doi.org/10.1111/dth.13663
Dermatologic Therapy; Baysak S, Kecici AS et. al.

May 24th, 2020 - This study aims to determine the efficacy of omalizumab, a humanized monoclonal anti-immunoglobulin E antibody, in patients with chronic spontaneous urticaria (CSU) refractory to conventional therapy, together with the evaluation of serum CRP leve...

Review on perfume and present status of its associated allergens.
https://doi.org/10.1111/jocd.13507
Journal of Cosmetic Dermatology; Kumar M, Devi A et. al.

May 23rd, 2020 - Perfume is basically a cosmetic product applied to human body for an amusing scent or the feeling of freshness. A certain amount of perfume penetrates and remains attached to the protein of the skin when perfume is applied on the body. It evokes a...

see more →

News  377 results

'COVID Toes' and 'Kawasaki' Rash: 5 Cutaneous Signs in COVID-19
https://www.medscape.com/viewarticle/930180

May 7th, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The skin manifestations of the novel coronavirus SARS-CoV-2 were not recognized at the early stages of the pandemic but have received much recent attention in sc...

Hypersensitivity Reactions to Orthopedic Implants: What’s All the Hype?
https://www.mdedge.com/dermatology/article/216696/contact-dermatitis/hypersensitivity-reactions-orthopedic-implants-whats/page/0/1?channel=54

Feb 4th, 2020 - Clinical Presentation Several clinical presentations of orthopedic IHRs have been described. Perhaps the most commonly recognized is a localized cutaneous eczematous eruption, with dermatitis typically overlying the site of the implanted material.

Fast Five Quiz: Chronic Spontaneous Urticaria
https://www.medscape.com/viewarticle/920709

Dec 18th, 2019 - Chronic spontaneous urticaria (CSU) (also referred to as "chronic idiopathic urticaria") represents the majority of cases of chronic urticaria. CSU is defined as chronic urticaria of known or unknown etiology lasting for ≥ 6 weeks. In a subset of ...

FDA OKs Cetirizine Injection (Quzyttir ) for Acute Urticaria
https://www.medscape.com/viewarticle/919911

Oct 14th, 2019 - The US Food and Drug Administration (FDA) has approved cetirizine hydrochloride for intravenous injection (Quzyttir, JDP Therapeutics) for treatment of acute urticaria in adults and children 6 months of age or older. Quzyttir will be available as ...

Ligelizumab May Improve Response in Chronic Urticaria
https://www.medscape.com/viewarticle/919360

Oct 2nd, 2019 - In the fight against chronic hives, the humanized anti-IgE monoclonal antibody ligelizumab may pack a more powerful punch than omalizumab (Xolar, Genentech), the previous top contender for trapping IgE antibodies for patients with chronic spontane...

see more →

Patient Education  17 results see all →